Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future
Systemic chemotherapy is one of the most important treatment modalities for advanced hepatocellular carcinoma (HCC). Before the introduction of sorafenib, cytotoxic agents, hormonal therapies, or many combinations of these were the mainly used modalities for systemic chemotherapy of advanced HCC. Ho...
Main Authors: | Masafumi Ikeda, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Hideaki Takahashi, Kazuo Watanabe, Kumiko Umemoto, Takuji Okusaka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-12-01
|
Series: | Diseases |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-9721/3/4/360 |
Similar Items
-
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
by: Kazuomi Ueshima, et al.
Published: (2020-07-01) -
Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience
by: Omar Abdel-Rahman, et al.
Published: (2014-03-01) -
Construction of pH-responsive nanocarriers in combination with ferroptosis and chemotherapy for treatment of hepatocellular carcinoma
by: Huan Yue, et al.
Published: (2022-01-01) -
NEXAVAR IN TREATMENT OF HEPATOCELLULAR CARCINOMA
by: Gabriela Smira, et al.
Published: (2018-12-01) -
Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma
by: Jun-Kyu Byun, et al.
Published: (2022-03-01)